Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
INVO Fertility ( (IVF) ) has provided an update.
On September 8, 2025, INVO Fertility, Inc. saw an institutional investor exercise its Additional Investment Right to acquire 200 shares of Series C-2 Convertible Preferred Stock for $200,000. This transaction adjusted the conversion price to $0.7362 per share and was executed without registration under the Securities Act, relying on exemptions for non-public offerings.
The most recent analyst rating on (IVF) stock is a Sell with a $1.50 price target. To see the full list of analyst forecasts on INVO Fertility stock, see the IVF Stock Forecast page.
Spark’s Take on IVF Stock
According to Spark, TipRanks’ AI Analyst, IVF is a Underperform.
The overall stock score is primarily impacted by poor financial performance and bearish technical indicators. The company’s significant operational losses and high leverage pose substantial risks. The negative P/E ratio and lack of dividend yield further weaken the valuation. Despite a positive corporate event, the overall outlook remains challenging.
To see Spark’s full report on IVF stock, click here.
More about INVO Fertility
Average Trading Volume: 1,589,876
Technical Sentiment Signal: Sell
Current Market Cap: $4.45M
See more data about IVF stock on TipRanks’ Stock Analysis page.